Robert H. Geelkerken
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Robert H. Geelkerken has a total of 160 co-authors. Here are the top co-authors by number of shared publications:
- Jeroen J. Kolkman
Department of gastroenterology, Medical Spectrum Twente, Enschede, The Netherlands
7 shared publications Adriaan Moelker
Department of Radiology, Erasmus MC University Medical Center, Rotterdam, the Netherlands
5 shared publications- Louisa J. D. van Dijk
Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands
5 shared publications Clark J. Zeebregts
Department of Surgery, Division of Vascular Surgery, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
4 shared publications- Jeroen J. Kolkman
Department of Gastroenterology and Hepatology, Medisch Spectrum Twente, Enschede, The Netherlands
4 shared publications Marco J. Bruno
Department of Gastroenterology and Hepatology, Erasmus MC University Medical Centre, Rotterdam, the Netherlands
4 shared publications
Latest Publications
- 27 February 2026
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 72 (3) , 469-470
Renal Artery Aneurysm: Primum Non Nocere
- 27 February 2026
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 72 (3) , 469-470
Renal Artery Aneurysm: Primum Non Nocere
- Open Access
- 5 August 2025
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 82 (6) , 2023-2035
Anatomical characteristics are associated with aneurysm sac regression after endovascular repair
- 5 August 2025
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 82 (6) , 2023-2035
Open AccessAnatomical characteristics are associated with aneurysm sac regression after endovascular repair
- Open Access
- 19 July 2025
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 71 (3) , 386-396
Impact of Endograft Fabric on Aneurysm Sac Remodelling after Elective Infrarenal Endovascular Aneurysm Repair
- 19 July 2025
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 71 (3) , 386-396
Open AccessImpact of Endograft Fabric on Aneurysm Sac Remodelling after Elective Infrarenal Endovascular Aneurysm Repair
- Open Access
- 18 July 2025
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 70 (3) , 295-305
Editor's Choice – Activated Clotting Time Guided Heparinisation during Open Abdominal Aortic Aneurysm Repair (ACTION-1): A Randomised, Multicentre, Single Blind, Superiority Trial
- 18 July 2025
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 70 (3) , 295-305
Open AccessEditor's Choice – Activated Clotting Time Guided Heparinisation during Open Abdominal Aortic Aneurysm Repair (ACTION-1): A Randomised, Multicentre, Single Blind, Superiority Trial
- Open Access
- 4 March 2025
- Published by Elsevier in Journal of Vascular Surgery Cases, Innovations and Techniques
- Vol. 11 (3) , 101770
Quantitative intra-arterial fluorescence angiography for direct monitoring of peripheral revascularization effects
- 4 March 2025
- Published by Elsevier in Journal of Vascular Surgery Cases, Innovations and Techniques
- Vol. 11 (3) , 101770
Open AccessQuantitative intra-arterial fluorescence angiography for direct monitoring of peripheral revascularization effects
- Open Access
Diagnostic potential of plasma biomarkers and exhaled volatile organic compounds in predicting the different stages of acute mesenteric ischaemia: protocol for a multicentre prospective observational study (TACTIC study)
Introduction Acute mesenteric ischaemia (AMI) is a life-threatening condition with short-term mortality of up to 80%. The diagnosis of AMI has remained troublesome due to the non-specific clinical presentation, symptoms and laboratory findings. Early unambiguous diagnosis of AMI is critical to prevent progression from reversible to irreversible transmural intestinal damage, thereby decreasing morbidity and improving survival. The present study aims to validate a panel of plasma biomarkers and investigate volatile organic compound (VOC) profiles in exhaled air as a tool to timely and accurately diagnose AMI. Methods and analysis In this international multicentre prospective observational study, 120 patients (>18 years of age) will be recruited with clinical suspicion of AMI. Clinical suspicion is based on: (1) clinical manifestation, (2) physical examination, (3) laboratory measurements and (4) the physician’s consideration to perform a CT scan. The patient’s characteristics, repetitive blood samples and exhaled air will be prospectively collected. Plasma levels of mucosal damage markers intestinal fatty acid-binding protein and villin-1, as well as transmural damage marker smooth muscle protein 22-alpha, will be assessed by ELISA. Analysis of VOCs in exhaled air will be performed by gas chromatography time-of-flight mass spectrometry. Diagnosis of AMI will be based on CT, endovascular and surgical reports, clinical findings, and (if applicable) verified by histopathological examination. Ethics and dissemination The study protocol was approved by the Medical Research Ethics Committee (METC) of Maastricht University Medical Centre+ and Maastricht University (METC azM/UM), the Netherlands (METC19-010) and the Ethics Committee Research UZ/KU Leuven, Belgium (S63500). Executive boards and local METCs of other Dutch participating centres Gelre Ziekenhuizen (Apeldoorn), Medisch Spectrum Twente (Enschede), and University Medical Centre Groningen have granted permission to carry out this study. Study results will be disseminated via open-access peer-reviewed scientific journals and national/international conferences. Trial registration number NCT05194527.
Open AccessDiagnostic potential of plasma biomarkers and exhaled volatile organic compounds in predicting the different stages of acute mesenteric ischaemia: protocol for a multicentre prospective observational study (TACTIC study)
Introduction Acute mesenteric ischaemia (AMI) is a life-threatening condition with short-term mortality of up to 80%. The diagnosis of AMI has remained troublesome due to the non-specific clinical presentation, symptoms and laboratory findings. Early unambiguous diagnosis of AMI is critical to prevent progression from reversible to irreversible transmural intestinal damage, thereby decreasing morbidity and improving survival. The present study aims to validate a panel of plasma biomarkers and investigate volatile organic compound (VOC) profiles in exhaled air as a tool to timely and accurately diagnose AMI. Methods and analysis In this international multicentre prospective observational study, 120 patients (>18 years of age) will be recruited with clinical suspicion of AMI. Clinical suspicion is based on: (1) clinical manifestation, (2) physical examination, (3) laboratory measurements and (4) the physician’s consideration to perform a CT scan. The patient’s characteristics, repetitive blood samples and exhaled air will be prospectively collected. Plasma levels of mucosal damage markers intestinal fatty acid-binding protein and villin-1, as well as transmural damage marker smooth muscle protein 22-alpha, will be assessed by ELISA. Analysis of VOCs in exhaled air will be performed by gas chromatography time-of-flight mass spectrometry. Diagnosis of AMI will be based on CT, endovascular and surgical reports, clinical findings, and (if applicable) verified by histopathological examination. Ethics and dissemination The study protocol was approved by the Medical Research Ethics Committee (METC) of Maastricht University Medical Centre+ and Maastricht University (METC azM/UM), the Netherlands (METC19-010) and the Ethics Committee Research UZ/KU Leuven, Belgium (S63500). Executive boards and local METCs of other Dutch participating centres Gelre Ziekenhuizen (Apeldoorn), Medisch Spectrum Twente (Enschede), and University Medical Centre Groningen have granted permission to carry out this study. Study results will be disseminated via open-access peer-reviewed scientific journals and national/international conferences. Trial registration number NCT05194527.
- Open Access
- 26 August 2023
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 67 (4) , 554-569
The Diagnostic Value of Biomarkers in Acute Mesenteric Ischaemia Is Insufficiently Substantiated: A Systematic Review
- 26 August 2023
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 67 (4) , 554-569
Open AccessThe Diagnostic Value of Biomarkers in Acute Mesenteric Ischaemia Is Insufficiently Substantiated: A Systematic Review
- 12 July 2023
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 66 (5) , 632-643
A Systematic Review of Endovascular Repair Outcomes in Atherosclerotic Chronic Mesenteric Ischaemia
- 12 July 2023
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 66 (5) , 632-643
A Systematic Review of Endovascular Repair Outcomes in Atherosclerotic Chronic Mesenteric Ischaemia